Yuji Sato

A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II

Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai et al. · Molecular Therapy · 2020 · 173 citations · Full text

Medicine, Neurology, Pharmacology +17

Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial

Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai et al. · Molecular Therapy · 2018 · 152 citations · Full text

Medicine, Neurology, Pharmacology +6

Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil

Roberto Giugliani, Ana Maria Martins, Sairei So et al. · Molecular Therapy · 2021 · 61 citations · Full text

Life Sciences, Neurology, Neuroscience +11

Designing an Encountered-type Haptic Display for Multiple Fingertip Contacts Based on the Observation of Human Grasping Behaviors

Yasuyoshi Yokokohji, Nobuhiko Muramori, Yuji Sato et al. · The International Journal of Robotics Research · 2005 · 47 citations

Engineering, Computer Science, Robotics Engineering +17

Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data

Roberto Giugliani, Ana Maria Martins, Torayuki Okuyama et al. · International Journal of Molecular Sciences · 2021 · 44 citations · Full text

Medicine, Neurology, Pharmacology +17